133 related articles for article (PubMed ID: 7681997)
1. Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases.
Haie-Meder C; Pellae-Cosset B; Laplanche A; Lagrange JL; Tuchais C; Nogues C; Arriagada R
Radiother Oncol; 1993 Feb; 26(2):111-6. PubMed ID: 7681997
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
3. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
4. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis.
Gelber RD; Larson M; Borgelt BB; Kramer S
Cancer; 1981 Oct; 48(8):1749-53. PubMed ID: 6169424
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases.
Rodrigues G; Yartsev S; Yaremko B; Perera F; Dar AR; Hammond A; Lock M; Yu E; Ash R; Caudrelier JM; Khuntia D; Bailey L; Bauman G
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1128-33. PubMed ID: 20675078
[TBL] [Abstract][Full Text] [Related]
6. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after whole brain reirradiation in patients with brain metastases.
Son CH; Jimenez R; Niemierko A; Loeffler JS; Oh KS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e167-72. PubMed ID: 21620583
[TBL] [Abstract][Full Text] [Related]
8. Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.
Assouline A; Levy A; Chargari C; Lamproglou I; Mazeron JJ; Krzisch C
Radiother Oncol; 2011 May; 99(2):214-7. PubMed ID: 21620502
[TBL] [Abstract][Full Text] [Related]
9. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases.
Graham PH; Bucci J; Browne L
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):648-54. PubMed ID: 19836153
[TBL] [Abstract][Full Text] [Related]
11. Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).
Ferro M; Chiesa S; Macchia G; Cilla S; Bertini F; Frezza G; Farioli A; Cammelli S; Balducci M; Ianiro A; Angelini AL; Compagnone G; Valentini V; Deodato F; Morganti AG
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):82-90. PubMed ID: 27843034
[TBL] [Abstract][Full Text] [Related]
12. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
13. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
14. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
Rades D; Heisterkamp C; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols.
Akhtar MS; Kousar F; Fatmi S; Jabeen K; Akhtar K
J Coll Physicians Surg Pak; 2012 May; 22(5):311-6. PubMed ID: 22538037
[TBL] [Abstract][Full Text] [Related]
16. Pulsed reduced dose-rate radiotherapy as re-irradiation for brain metastasis in a patient with lung squamous-celled carcinoma.
Li GH; Liu Y; Tang JL; Zhang D; Zhou P; Yang DQ; Ma CK
Jpn J Clin Oncol; 2012 Sep; 42(9):856-60. PubMed ID: 22701036
[TBL] [Abstract][Full Text] [Related]
17. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.
Tsao MN; Lloyd NS; Wong RK; Rakovitch E; Chow E; Laperriere N;
Cancer Treat Rev; 2005 Jun; 31(4):256-73. PubMed ID: 15951117
[TBL] [Abstract][Full Text] [Related]
19. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
20. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases.
Priestman TJ; Dunn J; Brada M; Rampling R; Baker PG
Clin Oncol (R Coll Radiol); 1996; 8(5):308-15. PubMed ID: 8934050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]